from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2460c/clpP2

LFCtreatmentdescriptionclass of inhibitor

-1.343

Amikacinug/mL Amikacintranslation

-1.200

Cap5-10ug/mL Capreomycintranslation

-2.343

Rox10-50 ug/mL Roxithromycintranslation

1.171

SM2-5 ug/mL Streptomycintranslation

-2.137

Tet5-10 ug/mL Tetracyclinetranslation

-0.667

Rif0.2-5ug/mL Rifampicintranscription

-2.134

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.107

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.036

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.580

CPZ10-50 ug/mL Chlorpromazinerespiration

0.544

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.272

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.361

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.429

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.008

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.056

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.682

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.952

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.478

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.154

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.537

KCN5-20 ug/mL Potassium cyaniderespiration

0.228

NaN30.2-2 mM Sodium aziderespiration

-0.290

Nigericin50 uM Nigericinrespiration

-0.148

TRC10-150 ug/mL Triclosanrespiration

0.921

TRZ10-25 ug/mL Thioridazinerespiration

-0.747

Valinomycin0.5-10 uM Valinomycinrespiration

0.186

ZnSO42 mM ZnSO4respiration

2.678

menadione6-10 ug/mL Menadionerespiration

0.755

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.220

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.058

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.064

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.694

NRP_1Non-replicating persistence stage 1dosRassociated

0.413

Amp0.2mg/mL AmpicillincellWall

-0.129

Cephalexin20-100 ug/mL CephalexincellWall

0.191

Cerulenin0.32-5 ug/mL CerulenincellWall

0.287

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.146

EMB10-20 ug/mL EthambutolcellWall

0.068

Eta12-40 ug/mL EthionamidecellWall

-0.296

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.069

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.730

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.867

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.480

BZA0.12 mg/mL BenzamidearomaticAmides

0.229

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.063

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.430

H2O24 mM hydrogen peroxideDNAdamaging

-0.258

Levo10 ug/mL LevofloxacinDNAdamaging

0.424

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.555

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.332

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.282

UVUV-irradiationDNAdamaging

0.550

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.408

Antimycin12.5-50 ug/mL Antimycin A?

-0.319

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.325

PA_110-50 ug/mL Antitubercular compound PA-1?

0.095

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.249

PA8240.2-2 ug/mL PA-824?

-0.439

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.010

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.044

Verapamil50 uM Verapamil?

-0.129

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.622

methoxatin10-20 ug/mL Methoxatin?